Levonorgestrel/Etinilestradiol Pensa (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the estrogen component, stabilises the endometrial lining and works together with levonorgestrel to suppress the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This inhibition prevents ovulation and, together with progestogen‑induced cervical mucus changes, reduces the chance of fertilisation and implantation.

The specific dosing regimen is determined by the prescribing healthcare professional based on the product’s labeling and the patient’s clinical needs. Typically, the medication is taken as one oral tablet daily, but the exact strength and schedule must be confirmed by the prescriber.

The product is contraindicated during pregnancy because it is intended to prevent conception, not to treat an existing pregnancy. While limited data exist for breastfeeding, caution is advised; healthcare providers usually assess the risk‑benefit ratio before recommending use in nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levonorgestrel/Etinilestradiol Pensa contains the same hormone classes as most combined oral contraceptives, offering comparable efficacy in preventing pregnancy. Differences may lie in the specific estrogen‑to‑progestogen ratio, tablet size, or formulation additives, which can influence tolerability, bleeding patterns and individual side‑effect profiles.

Store the tablets at ambient temperature, preferably below 25 °C (77 °F). Keep them in the original blister pack or container, protect from moisture and direct light, and ensure they are out of reach of children.

The medication is taken orally with a glass of water, preferably at the same time each day. It should be swallowed whole and not chewed or broken. Consistent daily intake maximises contraceptive effectiveness.

Serious but rare risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe hypertension, and hepatic adenoma. Patients should seek immediate medical attention if they experience symptoms such as sudden chest pain, shortness of breath, severe headache, visual changes, or unexplained swelling of the legs.

Women with a known history of thromboembolic disease, uncontrolled hypertension, active liver disease, breast cancer, or who are pregnant should avoid this product. Additionally, smokers over the age of 35 and individuals taking interacting enzyme‑inducing drugs should not use it without medical guidance.